RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Experimental Liver Neoplasms
Accession: DOID:9001586
browse the term
Definition: Experimentally induced tumors of the LIVER.
Synonyms: exact_synonym: Experimental Hepatomas; Experimental Liver Neoplasm; Morris Hepatoma; Novikoff hepatoma; experimental hepatoma
primary_id: MESH:D008114
G
Abcb11
ATP binding cassette subfamily B member 11
IDA
RGD
PMID:15853769
RGD:1598580
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
IEP
RGD
PMID:8104413
RGD:5684351
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Adsl
adenylosuccinate lyase
IEP
protein:increased activity:liver (rat)
RGD
PMID:2937404
RGD:1598766
NCBI chr 7:112,479,256...112,503,439
Ensembl chr 7:112,479,271...112,503,760
G
Afp
alpha-fetoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24012840 PMID:32961231
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Agps
alkylglycerone phosphate synthase
IDA
RGD
PMID:7407223
RGD:1598794
NCBI chr 3:60,747,323...60,845,831
Ensembl chr 3:60,747,323...60,845,830
G
Alas2
5'-aminolevulinate synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
G
Apoa4
apolipoprotein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Apoc2
apolipoprotein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Arid1a
AT-rich interaction domain 1A
disease_progression
ISO
RGD
PMID:26569409
RGD:11344640
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
G
Arrb2
arrestin, beta 2
IEP
mRNA, protein:increased expression:liver (rat)
RGD
PMID:21167192
RGD:5509890
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Atp7a
ATPase copper transporting alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Atp7b
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
G
Bak1
BCL2-antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bbc3
Bcl-2 binding component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10426811 PMID:28100771
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10426811 PMID:28100771 PMID:22414765
RGD:11353865
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Birc5
baculoviral IAP repeat-containing 5
IEP
mRNA, protein:increased expression:liver
RGD
PMID:18246794
RGD:2293125
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
IEP
protein:increased activity:liver (rat)
RGD
PMID:13618893
RGD:5132586
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
G
Car3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30603057
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccnb1
cyclin B1
IEP
mRNA:increased expression:liver
RGD
PMID:17342310
RGD:2315991
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28100771 PMID:17055752
RGD:2289139
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccndbp1
cyclin D1 binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16501603
NCBI chr 3:107,962,402...107,974,234
Ensembl chr 3:107,962,261...107,974,233
G
Ccng1
cyclin G1
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccng2
cyclin G2
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Cd40lg
CD40 ligand
ISO
RGD
PMID:19035311
RGD:5491179
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd63
Cd63 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:25319454
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
IEP
protein:decreased expression:liver:
RGD
PMID:8640740
RGD:8662309
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
disease_progression
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
disease_progression
IEP
protein:decreased expression:liver (rat) mRNA:increased expression:liver (rat) protein:increased expression:liver (rat)
RGD
PMID:26606000 PMID:19533683 PMID:3965145
RGD:11354707 , RGD:2315050 , RGD:152998958
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cops5
COP9 signalosome subunit 5
IEP
protein:increased expression:liver (rat)
RGD
PMID:26606000
RGD:11354707
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cps1
carbamoyl-phosphate synthase 1
severity
IEP
mRNA:decreased expression:liver
RGD
PMID:3387993
RGD:2303406
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11280770 PMID:20118494 PMID:21147764
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
mRNA:increased expression:liver
RGD
PMID:22687991
RGD:7296954
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11376689 PMID:21147764
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2a3
cytochrome P450, family 2, subfamily a, polypeptide 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18056438
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2f4
cytochrome P450, family 2, subfamily f, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
G
Dhodh
dihydroorotate dehydrogenase (quinone)
IEP
protein:increased activity:liver (rat)
RGD
PMID:6331524
RGD:5132618
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
G
Dtymk
deoxythymidylate kinase
IEP
protein:increased activity:tumor (rat)
RGD
PMID:6244089
RGD:5133686
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Ephx1
epoxide hydrolase 1
IEP
RGD
PMID:7260898
RGD:11252158
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35044086
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
F12
coagulation factor XII
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Foxm1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15082532
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Gjb1
gap junction protein, beta 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18308698 PMID:1336494
RGD:7349398
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
G
Gjb2
gap junction protein, beta 2
IEP
RGD
PMID:1336494
RGD:7349398
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Glul
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:21147764
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Grp
gastrin releasing peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
G
Gstp1
glutathione S-transferase pi 1
IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat)
CTD RGD
PMID:2563599 PMID:3124819 PMID:7585603 PMID:20188851 PMID:12016164 PMID:3965145 More...
RGD:2317823 , RGD:152998958
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
H19
H19 imprinted maternally expressed transcript
IDA ISO
DNA:hypomethylation:promoter CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11420682 PMID:15352122
RGD:1342455
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
Hat1
histone acetyltransferase 1
IEP
protein:increased expression:liver
RGD
PMID:17182829
RGD:2316578
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11896611
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Htr2c
5-hydroxytryptamine receptor 2C
IEP
protein:increased expression:brainstem, cerebral cortex
RGD
PMID:17258772
RGD:1624998
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Igf2
insulin-like growth factor 2
treatment
IEP
RGD
PMID:22425635
RGD:10402567
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Igf2r
insulin-like growth factor 2 receptor
IAGP
RGD
PMID:15057872 PMID:9652747
RGD:2311623 , RGD:2311630
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Il6
interleukin 6
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (mouse)
CTD RGD
PMID:26297436 PMID:26569409
RGD:11344640
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Insr
insulin receptor
disease_progression
IEP
associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat)
RGD
PMID:15520221
RGD:2306052
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
G
Jak2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kat6a
lysine acetyltransferase 6A
IEP
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chr16:69,084,914...69,165,923
Ensembl chr16:69,084,914...69,163,606
G
Kdr
kinase insert domain receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kras
KRAS proto-oncogene, GTPase
disease_progression
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat)
CTD RGD
PMID:8603461 PMID:19533683
RGD:2315050
NCBI chr 4:178,185,418...178,218,484
G
Map2k1
mitogen activated protein kinase kinase 1
IEP
associated with Diabetes Mellitus, Experimental;protein:increased expression:liver
RGD
PMID:15520221
RGD:2306052
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
G
Mir125a
microRNA 125a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
G
Mir145
microRNA 145
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir151
microRNA 151
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:105,172,377...105,172,473
G
Mir181c
microRNA 181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
G
Mir181d
microRNA 181d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr19:23,983,706...23,983,788
Ensembl chr19:23,983,706...23,983,788
G
Mir183
microRNA 183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:58,788,614...58,788,723
Ensembl chr 4:58,788,614...58,788,723
G
Mir186
microRNA 186
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:246,582,806...246,582,891
Ensembl chr 2:246,582,806...246,582,891
G
Mir18a
microRNA 18a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr15:92,180,765...92,180,860
Ensembl chr15:92,180,765...92,180,860
G
Mir193a
microRNA 193a
ISO
miRNA:decreased expression:liver (mouse)
RGD
PMID:30165047
RGD:153323340
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
G
Mir195
microRNA 195
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:54,951,838...54,951,924
Ensembl chr10:54,951,838...54,951,924
G
Mir196b
microRNA 196b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:81,330,487...81,330,571
Ensembl chr 4:81,330,487...81,330,571
G
Mir200b
microRNA 200b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
G
Mir206
microRNA 206
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
G
Mir212
microRNA 212
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:60,023,403...60,023,513
Ensembl chr10:60,023,403...60,023,513
G
Mir221
microRNA 221
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
G
Mir26a
microRNA 26a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 8:118,755,289...118,755,378
Ensembl chr 8:118,755,289...118,755,378
G
Mir26b
microRNA 26b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:75,976,596...75,976,680
Ensembl chr 9:75,976,596...75,976,680
G
Mir290
microRNA 290
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:65,964,648...65,964,728
Ensembl chr 1:65,964,648...65,964,728
G
Mir300
microRNA 300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:128,738,513...128,738,591
Ensembl chr 6:128,738,505...128,738,594
G
Mir301a
microRNA 301a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:71,925,336...71,925,435
Ensembl chr10:71,925,336...71,925,435
G
Mir30a
microRNA 30a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
G
Mir30b
microRNA 30b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:100,132,589...100,132,675
Ensembl chr 7:100,132,589...100,132,675
G
Mir30d
microRNA 30d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:100,136,391...100,136,472
Ensembl chr 7:100,136,391...100,136,472
G
Mir30e
microRNA 30e
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:134,352,232...134,352,323
Ensembl chr 5:134,352,232...134,352,323
G
Mir324
microRNA 324
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:54,734,680...54,734,762
Ensembl chr10:54,734,678...54,734,766
G
Mir331
microRNA 331
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
G
Mir336
microRNA 336
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:34,185,579...34,185,674
Ensembl chr10:34,185,579...34,185,674
G
Mir339
microRNA 339
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr12:15,277,546...15,277,641
Ensembl chr12:15,277,546...15,277,641
G
Mir340-1
microRNA 340-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:34,393,568...34,393,665
Ensembl chr10:34,393,568...34,393,665
G
Mir347
microRNA mir-347
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
G
Mir349
microRNA 349
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:120,243,311...120,243,407
Ensembl chr 7:120,243,311...120,243,407
G
Mir34a
microRNA 34a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
G
Mir352
microRNA mir-352
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
G
Mir383
microRNA 383
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr16:54,040,340...54,040,413
Ensembl chr16:54,040,340...54,040,413
G
Mir409
microRNA 409
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:128,757,780...128,757,856
Ensembl chr 6:128,757,779...128,757,858
G
Mir429
microRNA 429
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:166,647,459...166,647,543
Ensembl chr 5:166,647,459...166,647,543
G
Mir598
microRNA 598
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr15:37,962,692...37,962,770
Ensembl chr15:37,962,692...37,962,771
G
Mir652
microRNA 652
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:106,343,293...106,343,373
Ensembl chr X:106,343,293...106,343,373
G
Mir671
microRNA 671
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:10,580,747...10,580,827
Ensembl chr 4:10,580,738...10,580,835
G
Mir708
microRNA 708
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:150,599,876...150,599,963
Ensembl chr 1:150,599,876...150,599,963
G
Mir760
microRNA 760
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:210,392,616...210,392,695
Ensembl chr 2:210,392,616...210,392,695
G
Mir92b
microRNA 92b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:174,633,890...174,633,972
Ensembl chr 2:174,633,890...174,633,972
G
Mir98
microRNA 98
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:20,981,235...20,981,342
Ensembl chr X:20,981,235...20,981,342
G
Mir99b
microRNA 99b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:58,677,015...58,677,084
Ensembl chr 1:58,677,011...58,677,090
G
Mirlet7b
microRNA let-7b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:116,804,186...116,804,270
Ensembl chr 7:116,804,186...116,804,270
G
Mirlet7d
microRNA let-7d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr17:16,115,893...16,115,990
Ensembl chr17:16,115,893...16,115,990
G
Mirlet7i
microRNA let-7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:58,642,485...58,642,569
Ensembl chr 7:58,642,480...58,642,571
G
Mmp2
matrix metallopeptidase 2
IEP ISO
mRNA, protein:increased expression, increased activity:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30603057 PMID:19528495 PMID:19539802
RGD:2325736 , RGD:2325734
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
IEP
mRNA, protein:increased expression, increased activity:liver
RGD
PMID:19528495 PMID:19539802
RGD:2325736 , RGD:2325734
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpeg1
macrophage expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
G
Myc
MYC proto-oncogene, bHLH transcription factor
IEP ISO
mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9079223 PMID:11280770 PMID:18560566 PMID:3335218
RGD:10059623
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nos2
nitric oxide synthase 2
IEP
protein:increased expression:liver
RGD
PMID:10383909
RGD:2325277
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
IEP
protein:increased expression:liver
RGD
PMID:18942116
RGD:2325310
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nqo1
NAD(P)H quinone dehydrogenase 1
IEP
mRNA, protein:increased expression:liver (rat)
RGD
PMID:27867096
RGD:13442478
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
susceptibility
ISO
RGD
PMID:17283114
RGD:14701032
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17172636 PMID:24769335 PMID:25656644
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nras
NRAS proto-oncogene, GTPase
ISO
human gene in mouse model
RGD
PMID:16286660
RGD:14975105
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Pemt
phosphatidylethanolamine N-methyltransferase
IEP
protein:decreased expression:liver
RGD
PMID:7929120
RGD:1642378
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
G
Plcl1
phospholipase C-like 1
disease_progression
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chr 9:56,901,573...57,238,782
Ensembl chr 9:56,901,534...57,238,782
G
Pml
PML nuclear body scaffold
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20377131
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:761203
NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:2562181
RGD:8693574
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Prdx1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Ptgr1
prostaglandin reductase 1
IEP
mRNA, protein:increased expression:liver
RGD
PMID:24853774
RGD:14401713
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Rad51
RAD51 recombinase
IEP
protein:decreased expression:liver
RGD
PMID:17219426
RGD:2292638
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17854601
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rida
reactive intermediate imine deaminase A homolog
IEP
protein:increased expression:liver (rat)
RGD
PMID:12939504
RGD:9685719
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
G
Rras2
RAS related 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
Rrm1
ribonucleotide reductase catalytic subunit M1
IEP
RGD
PMID:15224347
RGD:2316863
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
G
Rxra
retinoid X receptor alpha
IEP
mRNA, protein:decreased expression:liver
RGD
PMID:17786350
RGD:1643105
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Serpina1
serpin family A member 1
IEP
RGD
PMID:10569800
RGD:1626391
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Slc31a1
solute carrier family 31 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc7a5
solute carrier family 7 member 5
IEP
mRNA:increased expression:liver
RGD
PMID:17498859
RGD:151357003
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Snx27
sorting nexin 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36029209
NCBI chr 2:182,135,904...182,218,906
Ensembl chr 2:182,135,905...182,218,906
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15197228
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Sox4
SRY-box transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Sqle
squalene epoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26297436 PMID:28100771
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tek
TEK receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
G
Tgfa
transforming growth factor alpha
IEP ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9079223 PMID:16734725
RGD:2317490
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tk1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tnf
tumor necrosis factor
treatment disease_progression
ISO
CTD Direct Evidence: marker/mechanism Morris hepatoma protein:increased expression:blood serum (mouse)
CTD RGD
PMID:28100771 PMID:9063767 PMID:26569409
RGD:14696818 , RGD:11344640
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10626228 PMID:28100771
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15833021 PMID:17533171
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Vim
vimentin
IDA
RGD
PMID:19199359
RGD:6480440
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Xdh
xanthine dehydrogenase
IEP
protein:decreased expression:liver
RGD
PMID:3460692
RGD:13210515
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all